enVVeno Medical (NVNO) Competitors

$10.68 -0.28 (-2.55%)

Closing price 05/22/2026 03:50 PM Eastern

Extended Trading

$9.60 -1.08 (-10.10%)

As of 05/22/2026 05:00 PM Eastern

NVNO vs. FEMY, POAI, RVP, OSRH, and ICCM

Should you buy enVVeno Medical stock or one of its competitors? MarketBeat compares enVVeno Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with enVVeno Medical include Femasys (FEMY), Predictive Oncology (POAI), Retractable Technologies (RVP), OSR (OSRH), and IceCure Medical (ICCM). These companies are all part of the "medical equipment" industry.

How does enVVeno Medical compare to Femasys?

Femasys (NASDAQ:FEMY) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

Femasys has higher revenue and earnings than enVVeno Medical. Femasys is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	11.55	-$18.63M	-$0.27	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A

In the previous week, Femasys had 2 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for Femasys and 0 mentions for enVVeno Medical. Femasys' average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.

Company	Overall Sentiment
Femasys	Neutral
enVVeno Medical	Neutral

enVVeno Medical has a net margin of 0.00% compared to Femasys' net margin of -521.97%. enVVeno Medical's return on equity of -66.39% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-521.97%	-258.08%	-73.72%
enVVeno Medical	N/A	-66.39%	-60.42%

65.3% of Femasys shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 7.6% of Femasys shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Femasys has a beta of -2.26, meaning that its stock price is 326% less volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

Femasys presently has a consensus target price of $5.33, indicating a potential upside of 1,117.66%. Given Femasys' stronger consensus rating and higher probable upside, equities analysts clearly believe Femasys is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

Femasys beats enVVeno Medical on 8 of the 14 factors compared between the two stocks.

How does enVVeno Medical compare to Predictive Oncology?

Predictive Oncology (NASDAQ:POAI) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

9.0% of Predictive Oncology shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 1.2% of Predictive Oncology shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Predictive Oncology has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market.

Predictive Oncology has higher revenue and earnings than enVVeno Medical. enVVeno Medical is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$1.66M	10.89	-$12.66M	-$13.50	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A

In the previous week, Predictive Oncology's average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.

Company	Overall Sentiment
Predictive Oncology	Neutral
enVVeno Medical	Neutral

enVVeno Medical has a net margin of 0.00% compared to Predictive Oncology's net margin of -5,065.23%. enVVeno Medical's return on equity of -66.39% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-5,065.23%	-732.73%	-235.55%
enVVeno Medical	N/A	-66.39%	-60.42%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

enVVeno Medical beats Predictive Oncology on 6 of the 11 factors compared between the two stocks.

How does enVVeno Medical compare to Retractable Technologies?

Retractable Technologies (NYSE:RVP) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Retractable Technologies has higher revenue and earnings than enVVeno Medical. Retractable Technologies is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.57	-$7.01M	-$0.21	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Retractable Technologies has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.08, meaning that its stock price is 8% more volatile than the broader market.

In the previous week, enVVeno Medical's average media sentiment score of 0.00 beat Retractable Technologies' score of -1.00 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Negative
enVVeno Medical	Neutral

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Comparatively, 15.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

enVVeno Medical has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat enVVeno Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
enVVeno Medical	N/A	-66.39%	-60.42%

Summary

Retractable Technologies beats enVVeno Medical on 7 of the 12 factors compared between the two stocks.

How does enVVeno Medical compare to OSR?

enVVeno Medical (NASDAQ:NVNO) and OSR (NASDAQ:OSRH) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

enVVeno Medical has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market. Comparatively, OSR has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

In the previous week, enVVeno Medical's average media sentiment score of 0.00 equaled OSR'saverage media sentiment score.

Company	Overall Sentiment
enVVeno Medical	Neutral
OSR	Neutral

enVVeno Medical has a net margin of 0.00% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat enVVeno Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
enVVeno Medical	N/A	-66.39%	-60.42%
OSR	-363.26%	-7.24%	-5.41%

34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 55.3% of OSR shares are held by institutional investors. 15.0% of enVVeno Medical shares are held by company insiders. Comparatively, 60.6% of OSR shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

enVVeno Medical has higher earnings, but lower revenue than OSR. OSR is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A
OSR	$2.91M	6.06	-$27.06M	-$0.33	N/A

Summary

OSR beats enVVeno Medical on 6 of the 11 factors compared between the two stocks.

How does enVVeno Medical compare to IceCure Medical?

IceCure Medical (NASDAQ:ICCM) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

IceCure Medical has higher revenue and earnings than enVVeno Medical. IceCure Medical is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	5.65	-$15.06M	-$0.24	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$25.54	N/A

IceCure Medical presently has a consensus target price of $2.09, indicating a potential upside of 789.36%. Given IceCure Medical's stronger consensus rating and higher probable upside, research analysts plainly believe IceCure Medical is more favorable than enVVeno Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, IceCure Medical had 2 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for IceCure Medical and 0 mentions for enVVeno Medical. IceCure Medical's average media sentiment score of 0.61 beat enVVeno Medical's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.

Company	Overall Sentiment
IceCure Medical	Positive
enVVeno Medical	Neutral

IceCure Medical has a beta of 0.47, indicating that its stock price is 53% less volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 15.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

enVVeno Medical has a net margin of 0.00% compared to IceCure Medical's net margin of -441.60%. enVVeno Medical's return on equity of -66.39% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-441.60%	-211.73%	-119.13%
enVVeno Medical	N/A	-66.39%	-60.42%

Summary

IceCure Medical beats enVVeno Medical on 8 of the 15 factors compared between the two stocks.

Get enVVeno Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVNO vs. The Competition

Export

Metric	enVVeno Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$7.32M	$7.10B	$6.46B	$12.34B
Dividend Yield	N/A	1.68%	2.76%	5.28%
P/E Ratio	-0.42	47.45	21.00	25.66
Price / Sales	N/A	73.72	558.19	86.31
Price / Cash	N/A	24.91	43.49	56.67
Price / Book	0.30	6.53	10.40	7.14
Net Income	-$19.47M	$158.81M	$3.57B	$335.98M
7 Day Performance	5.22%	3.61%	6.40%	4.11%
1 Month Performance	-18.16%	0.74%	3.55%	2.52%
1 Year Performance	-90.89%	3.17%	34.13%	35.04%

enVVeno Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVNO enVVeno Medical	0.7523 of 5 stars	$10.68 -2.6%	N/A	-90.9%	$7.32M	N/A	N/A	30
FEMY Femasys	2.1398 of 5 stars	$0.38 +1.1%	$5.33 +1,298.4%	-57.9%	$23.03M	$2.38M	N/A	30	Gap Down
POAI Predictive Oncology	0.0415 of 5 stars	$6.66 flat	N/A	-63.5%	$22.60M	$1.66M	N/A	30
RVP Retractable Technologies	N/A	$0.69 -2.4%	N/A	+9.9%	$20.51M	$38.27M	N/A	240	Negative News Gap Down
OSRH OSR	0.4728 of 5 stars	$0.62 -4.0%	N/A	-56.7%	$20.43M	$2.91M	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NVNO) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

enVVeno Medical (NVNO) Competitors

NVNO vs. FEMY, POAI, RVP, OSRH, and ICCM

How does enVVeno Medical compare to Femasys?

Summary

How does enVVeno Medical compare to Predictive Oncology?

Summary

How does enVVeno Medical compare to Retractable Technologies?

Summary

How does enVVeno Medical compare to OSR?

Summary

How does enVVeno Medical compare to IceCure Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

enVVeno Medical (NVNO) Competitors

NVNO vs. FEMY, POAI, RVP, OSRH, and ICCM

How does enVVeno Medical compare to Femasys?

Which has higher valuation and earnings, FEMY or NVNO?

Does the media favor FEMY or NVNO?

Is FEMY or NVNO more profitable?

Do insiders & institutionals have more ownership in FEMY or NVNO?

Which has more risk & volatility, FEMY or NVNO?

Do analysts rate FEMY or NVNO?

Summary

How does enVVeno Medical compare to Predictive Oncology?

Do institutionals and insiders hold more shares of POAI or NVNO?

Which has more volatility & risk, POAI or NVNO?

Which has better valuation & earnings, POAI or NVNO?

Does the media prefer POAI or NVNO?

Is POAI or NVNO more profitable?

Do analysts rate POAI or NVNO?

Summary

How does enVVeno Medical compare to Retractable Technologies?

Which has higher earnings & valuation, RVP or NVNO?

Do analysts recommend RVP or NVNO?

Which has more volatility and risk, RVP or NVNO?

Does the media favor RVP or NVNO?

Do insiders & institutionals have more ownership in RVP or NVNO?

Is RVP or NVNO more profitable?

Summary

How does enVVeno Medical compare to OSR?

Which has more risk & volatility, NVNO or OSRH?

Does the media prefer NVNO or OSRH?

Is NVNO or OSRH more profitable?

Do institutionals and insiders have more ownership in NVNO or OSRH?

Do analysts recommend NVNO or OSRH?

Which has better earnings and valuation, NVNO or OSRH?

Summary

How does enVVeno Medical compare to IceCure Medical?

Which has preferable earnings & valuation, ICCM or NVNO?

Do analysts prefer ICCM or NVNO?

Does the media favor ICCM or NVNO?

Which has more risk & volatility, ICCM or NVNO?

Do insiders & institutionals believe in ICCM or NVNO?

Is ICCM or NVNO more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools